<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>174(9)</volume><submitter>Nehme M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>With millions of SARS-CoV-2 infections worldwide, increasing numbers of patients are coming forward with long-term clinical effects of the disease lasting several weeks to months.&lt;h4>Objective&lt;/h4>To characterize symptoms 7 to 9 months after diagnosis of COVID-19.&lt;h4>Design&lt;/h4>Self-reported surveys and semistructured telephone interviews at enrollment and 30 to 45 days and 7 to 9 months from diagnosis.&lt;h4>Setting&lt;/h4>From 18 March to 15 May 2020, symptomatic persons who tested positive for SARS-CoV-2 at the Geneva University Hospitals were followed by CoviCare, a virtual, clinical, outpatient follow-up program. Persons were contacted again at 30 to 45 days and 7 to 9 months from diagnosis.&lt;h4>Participants&lt;/h4>Persons who were a part of the CoviCare program from 18 March</pubmed_abstract><journal>Annals of internal medicine</journal><pagination>1252-1260</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8280535</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting.</pubmed_title><pmcid>PMC8280535</pmcid><pubmed_authors>CoviCare Study Team</pubmed_authors><pubmed_authors>Innaurato G</pubmed_authors><pubmed_authors>Lebowitz D</pubmed_authors><pubmed_authors>Genecand C</pubmed_authors><pubmed_authors>Grira M</pubmed_authors><pubmed_authors>Braillard O</pubmed_authors><pubmed_authors>Allali G</pubmed_authors><pubmed_authors>Courvoisier DS</pubmed_authors><pubmed_authors>Chevallier-Lugon C</pubmed_authors><pubmed_authors>Lab B</pubmed_authors><pubmed_authors>Regard S</pubmed_authors><pubmed_authors>Nehme M</pubmed_authors><pubmed_authors>Alcoba G</pubmed_authors><pubmed_authors>Chappuis F</pubmed_authors><pubmed_authors>Spechbach H</pubmed_authors><pubmed_authors>Tardin A</pubmed_authors><pubmed_authors>Sandoval J</pubmed_authors><pubmed_authors>Guessous I</pubmed_authors><pubmed_authors>Aebischer Perone S</pubmed_authors><pubmed_authors>Kopp G</pubmed_authors><pubmed_authors>Socquet J</pubmed_authors><pubmed_authors>Lador F</pubmed_authors><pubmed_authors>Carnino L</pubmed_authors><pubmed_authors>Koegler F</pubmed_authors><pubmed_authors>Salamun J</pubmed_authors><pubmed_authors>Baggio S</pubmed_authors><pubmed_authors>Benzakour L</pubmed_authors><pubmed_authors>Stringhini S</pubmed_authors><pubmed_authors>Agoritsas T</pubmed_authors><pubmed_authors>Chopard P</pubmed_authors><pubmed_authors>Jacquerioz F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting.</name><description>&lt;h4>Background&lt;/h4>With millions of SARS-CoV-2 infections worldwide, increasing numbers of patients are coming forward with long-term clinical effects of the disease lasting several weeks to months.&lt;h4>Objective&lt;/h4>To characterize symptoms 7 to 9 months after diagnosis of COVID-19.&lt;h4>Design&lt;/h4>Self-reported surveys and semistructured telephone interviews at enrollment and 30 to 45 days and 7 to 9 months from diagnosis.&lt;h4>Setting&lt;/h4>From 18 March to 15 May 2020, symptomatic persons who tested positive for SARS-CoV-2 at the Geneva University Hospitals were followed by CoviCare, a virtual, clinical, outpatient follow-up program. Persons were contacted again at 30 to 45 days and 7 to 9 months from diagnosis.&lt;h4>Participants&lt;/h4>Persons who were a part of the CoviCare program from 18 March</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-20T02:41:02.476Z</modification><creation>2022-02-10T20:50:49.722Z</creation></dates><accession>S-EPMC8280535</accession><cross_references><pubmed>34224254</pubmed><doi>10.7326/M21-0878</doi></cross_references></HashMap>